Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DISCORD-Dx as a Cognitive Strategy for Calibrated Reliance on AI in Diagnosis

NCT07844889 is registered in ClinicalTrials.gov with Sara Reza as lead sponsor.

NCT NCT07844889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07844889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DISCORD-Dx as a Cognitive Strategy for Calibrated Reliance on AI in Diagnosis
Lead sponsor
Sara Reza
Phase
Not applicable
Overall status
Completed
Start date
June 6, 2026
Completion date
September 2, 2026
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence (ai) in diagnosis, decision making